| Indicators | Browse All

Drugs Made In America Acquisition II Corp. (DMII)

Financial Services | Shell Companies | New York, United States | NasdaqGM
10.19 USD

Short-term:★★⯪☆☆Long-term:☆☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 5:21 a.m. EDT

This shell company presents a binary risk profile with no path to standard investment success. Fundamentally, the balance sheet is broken, showing negative book value and significant operating cash outflows, while the entity holds no revenue or earnings history to support a valuation. The lack of any dividend history confirms it is purely a speculative vehicle waiting for a SPAC merger, offering zero income and high capital risk if the deal fails. While the short-term statistical model indicates a very high probability of a minor price uptick due to tight trading ranges, this is merely noise reflecting the artificial price floor of a shell company rather than genuine business momentum. There is no long-term business quality here to justify holding through the uncertainty of a potential merger.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.001051
AutoARIMA0.001077
AutoETS0.001078
AutoTheta0.002619

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 86%
H-stat 3.21
Ljung-Box p 0.000
Jarque-Bera p 0.368
Excess Kurtosis -0.85
Attribute Value
Sector Financial Services
Market Cap 649,102,976
Trailing P/E 33.97

Info Dump

Attribute Value
52 Week Change 0.03137648
Address1 420 Lexington Avenue
Address2 Suite 1402
All Time High 10.33
All Time Low 9.86
Ask 10.09
Ask Size 2
Average Daily Volume10 Day 245,940
Average Daily Volume3 Month 85,615
Average Volume 85,615
Average Volume10Days 245,940
Bid 10.11
Bid Size 1
Book Value -0.281
City New York
Country United States
Crypto Tradeable 0
Currency USD
Current Price 10.19
Current Ratio 0.338
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 10.19
Day Low 10.18
Display Name Drugs Made In America Acq II
Dividend Yield 0.0
Ebitda Margins 0.0
Enterprise Value 649,378,048
Eps Trailing Twelve Months 0.3
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 10.15656
Fifty Day Average Change 0.033439636
Fifty Day Average Change Percent 0.0032924176
Fifty Two Week Change Percent 3.137648
Fifty Two Week High 10.33
Fifty Two Week High Change -0.14000034
Fifty Two Week High Change Percent -0.013552792
Fifty Two Week Low 9.86
Fifty Two Week Low Change 0.32999992
Fifty Two Week Low Change Percent 0.033468552
Fifty Two Week Range 9.86 - 10.33
Financial Currency USD
First Trade Date Milliseconds 1,764,772,200,000
Float Shares 54,008,045
Full Exchange Name NasdaqGM
Fullday Change 0.0
Fullday Change Percent 0.0
Fullday Price 10.19
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.15215
Held Percent Institutions 0.7288
Implied Shares Outstanding 63,700,000
Industry Shell Companies
Industry Disp Shell Companies
Industry Key shell-companies
Ipo Expected Date 2,025-12-03
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
Long Name Drugs Made In America Acquisition II Corp.
Market us_market
Market Cap 649,102,976
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_1938104325
Most Recent Quarter 1,782,777,600
Net Income To Common 13,018,726
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 647,192,000
Open 10.19
Operating Cashflow -1,280,839
Operating Margins 0.0
Payout Ratio 0.0
Phone 917 982 4565
Previous Close 10.19
Price Hint 2
Price To Book -36.263344
Profit Margins 0.0
Quick Ratio 0.271
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0
Regular Market Change Percent 0.0
Regular Market Day High 10.19
Regular Market Day Low 10.18
Regular Market Day Range 10.18 - 10.19
Regular Market Open 10.19
Regular Market Previous Close 10.19
Regular Market Price 10.19
Regular Market Time 1,792,094,400
Regular Market Volume 121,799
Sand P52 Week Change 0.16440773
Sector Financial Services
Sector Disp Financial Services
Sector Key financial-services
Shares Outstanding 63,700,000
Shares Percent Shares Out 0.0019
Shares Short 121,549
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 119,323
Short Name Drugs Made In America Acquisiti
Short Percent Of Float 0.002
Short Ratio 2.38
Source Interval 15
State NY
Symbol DMII
Total Cash 174,974
Total Cash Per Share 0.003
Total Debt 450,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 0.3
Trailing P E 33.966663
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 10.050745
Two Hundred Day Average Change 0.13925457
Two Hundred Day Average Change Percent 0.013855149
Type Disp Equity
Volume 121,799
Zip 10,170